Education
About Us
Working with TipRanks
Follow Us
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
Total Valuation
Intensity Therapeutics, Inc. has a market cap or net worth of $25.53M. The enterprise value is $3.70M.
Market Cap$25.53M
Enterprise Value$3.70M
Share Statistics
Intensity Therapeutics, Inc. has 60,064,964 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding60,064,964
Owned by Insiders0.15%
Owned by Institutions3.41%
Financial Efficiency
Intensity Therapeutics, Inc.’s return on equity (ROE) is -5.58 and return on invested capital (ROIC) is -542.70%.
Return on Equity (ROE)-5.58
Return on Assets (ROA)-3.40
Return on Invested Capital (ROIC)-542.70%
Return on Capital Employed (ROCE)-5.48
Revenue Per Employee0.00
Profits Per Employee-3.25M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Intensity Therapeutics, Inc. is ―. Intensity Therapeutics, Inc.’s PEG ratio is 0.10.
PE Ratio―
PS Ratio0.00
PB Ratio8.39
Price to Fair Value8.39
Price to FCF-1.61
Price to Operating Cash Flow-1.87
PEG Ratio0.10
Income Statement
In the last 12 months, Intensity Therapeutics, Inc. had revenue of 0.00 and earned -16.27M in profits. Earnings per share was -1.17.
Revenue0.00
Gross Profit0.00
Operating Income-16.59M
Pretax Income-16.27M
Net Income-16.27M
EBITDA-16.27M
Earnings Per Share (EPS)-1.17
Cash Flow
In the last 12 months, operating cash flow was -9.50M and capital expenditures 0.00, giving a free cash flow of -9.50M billion.
Operating Cash Flow-9.50M
Free Cash Flow-9.50M
Free Cash Flow per Share-0.16
Dividends & Yields
Intensity Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-84.86%
50-Day Moving Average0.44
200-Day Moving Average0.50
Relative Strength Index (RSI)50.07
Average Volume (3m)5.11M
Important Dates
Intensity Therapeutics, Inc. upcoming earnings date is Mar 12, 2026, Before Open (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Intensity Therapeutics, Inc. as a current ratio of 1.92, with Debt / Equity ratio of 1.63%
Current Ratio1.92
Quick Ratio1.92
Debt to Market Cap0.00
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Intensity Therapeutics, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Intensity Therapeutics, Inc. EV to EBITDA ratio is -1.36, with an EV/FCF ratio of -1.45.
EV to Sales0.00
EV to EBITDA-1.36
EV to Free Cash Flow-1.45
EV to Operating Cash Flow-1.45
Balance Sheet
Intensity Therapeutics, Inc. has $7.07M in cash and marketable securities with $118.00K in debt, giving a net cash position of $6.95M billion.
Cash & Marketable Securities$7.07M
Total Debt$118.00K
Net Cash$6.95M
Net Cash Per Share$0.12
Tangible Book Value Per Share$0.21
Margins
Gross margin is -4.17%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-4.17%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Intensity Therapeutics, Inc. is $3.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$3.33
Price Target Upside692.86% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast46.41%